These findings are aligned with previous reports showing that blocking the classical RAS axis and activating the ACE2/Ang1‐7 axis elicited beneficial effects in NAFLD (Takahashi et al. 2007; Jayasooriya et al. 2008; Cao et al. 2016; Attia et al. 2022). This evidence concerns the gene ACE2 and metabolic dysfunction-associated steatotic liver disease.